Sarilumab Treatment In cytoKinE Storm Caused by Infection With COVID-19

NCT04661527 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

COVID-19 Drug Treatment

Interventions

DRUG: Sarilumab

Sponsor

Clinica Universidad de Navarra, Universidad de Navarra

Collaborators

[object Object]
[object Object]